Industry News
In HER2 positive breast cancer, novel immunotherapy vaccine decreases recurrence
Sep 09, 2014
A new breast cancer vaccine candidate, (GP2), provides further evidence of the potential of immunotherapy in preventing disease recurrence. Read More
Advance reported in treatment of triple-negative breast cancer
Sep 09, 2014
William M. Sikov, a medical oncologist in the Breast Health Center and associate director for clinical research in the Program in Women's Oncology at Women & Infants Hospital of Rhode Island, served... Read More
97 percent of elderly patients aged above 80 years recover without major complications after breast cancer surgery
Sep 09, 2014
A study conducted by National Cancer Centre Singapore (NCCS) has shown that age per se is not a contraindication to breast cancer surgery, and such surgeries may be safely performed for women aged 80... Read More
Should lung cancer screening be covered for Medicare beneficiaries?
Sep 08, 2014
Researchers for the Centers for Medicare and Medicaid Services (CMS) analyze evidence on the benefits and harms of lung cancer screening by age in a study being published in Annals of Internal... Read More
Hourly 5-minute walks 'reverse arterial damage caused by sitting'
Sep 08, 2014
Prolonged periods of sitting can reduce the function of arteries in the legs. A new study finds that this reduced function can be avoided by taking short walking breaks. Read More
New blood test could offer more tailored treatment of ovarian cancer
Sep 08, 2014
A new blood test allowing doctors to predict which ovarian cancer patients will respond to particular types of treatment is a step closer following a new study by Manchester scientists. Read More
New blood test could offer more tailored treatment of ovarian cancer
Sep 08, 2014
A new blood test allowing doctors to predict which ovarian cancer patients will respond to particular types of treatment is a step closer following a new study by Manchester scientists. Read More
Phase III FIRST trial results of REVLIMID® Plus Dexamethasone in newly diagnosed multiple myeloma patients published
Sep 08, 2014
Celgene Corporation has announced that data from FIRST (MM-020/IFM 07-01) - an open-label phase III randomized study of continuous REVLIMID (lenalidomide) in combination with dexamethasone in... Read More
A minimally invasive, high-performance intervention for staging lung cancer
Sep 08, 2014
Endoscopic biopsy of lymph nodes between the two lungs (mediastinum) is a sensitive and accurate technique that can replace mediastinal surgery for staging lung cancer in patients with potentially... Read More
Gene patent laws must change to protect Australian healthcare consumers
Sep 08, 2014
The Federal Court's dismissal of an appeal against the patenting of genetic mutations associated with breast and ovarian cancer highlights why patent law in Australia needs to change, Cancer... Read More
Previous Page Next Page